The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Paclitaxel Drug-Eluting Balloon Market Research Report 2024
Synopsis
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
Global Paclitaxel Drug-Eluting Balloon market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Paclitaxel Drug-Eluting Balloon market research.
Key manufacturers engaged in the Paclitaxel Drug-Eluting Balloon industry include Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, Aachen Resonance, QT Vascular, Biotronic and Philips, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Paclitaxel Drug-Eluting Balloon were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Paclitaxel Drug-Eluting Balloon market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Paclitaxel Drug-Eluting Balloon market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
Boston Scientific
B. Braun
Cook Medical
Cardionovum
Aachen Resonance
QT Vascular
Biotronic
Philips
Eurocor
Yinyi Biotech
Lepu Medical Technology
Segment by Type
Balloon-Only Coating
Drug-Coated Balloon
Segment by Application
Peripheral Artery Disease
Coronary Artery Disease
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Paclitaxel Drug-Eluting Balloon report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
Global Paclitaxel Drug-Eluting Balloon market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Paclitaxel Drug-Eluting Balloon market research.
Key manufacturers engaged in the Paclitaxel Drug-Eluting Balloon industry include Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, Aachen Resonance, QT Vascular, Biotronic and Philips, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Paclitaxel Drug-Eluting Balloon were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Paclitaxel Drug-Eluting Balloon market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Paclitaxel Drug-Eluting Balloon market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medtronic
Boston Scientific
B. Braun
Cook Medical
Cardionovum
Aachen Resonance
QT Vascular
Biotronic
Philips
Eurocor
Yinyi Biotech
Lepu Medical Technology
Segment by Type
Balloon-Only Coating
Drug-Coated Balloon
Segment by Application
Peripheral Artery Disease
Coronary Artery Disease
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Paclitaxel Drug-Eluting Balloon report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Paclitaxel Drug-Eluting Balloon Market Overview
1.1 Product Overview and Scope of Paclitaxel Drug-Eluting Balloon
1.2 Paclitaxel Drug-Eluting Balloon Segment by Type
1.2.1 Global Paclitaxel Drug-Eluting Balloon Market Value Comparison by Type (2023-2029)
1.2.2 Balloon-Only Coating
1.2.3 Drug-Coated Balloon
1.3 Paclitaxel Drug-Eluting Balloon Segment by Application
1.3.1 Global Paclitaxel Drug-Eluting Balloon Market Value by Application: (2023-2029)
1.3.2 Peripheral Artery Disease
1.3.3 Coronary Artery Disease
1.4 Global Paclitaxel Drug-Eluting Balloon Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Drug-Eluting Balloon Revenue 2018-2029
1.4.2 Global Paclitaxel Drug-Eluting Balloon Sales 2018-2029
1.4.3 Global Paclitaxel Drug-Eluting Balloon Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Paclitaxel Drug-Eluting Balloon Market Competition by Manufacturers
2.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Manufacturers (2018-2023)
2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturers (2018-2023)
2.4 Global Paclitaxel Drug-Eluting Balloon Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel Drug-Eluting Balloon, Product Type & Application
2.7 Paclitaxel Drug-Eluting Balloon Market Competitive Situation and Trends
2.7.1 Paclitaxel Drug-Eluting Balloon Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel Drug-Eluting Balloon Players Market Share by Revenue
2.7.3 Global Paclitaxel Drug-Eluting Balloon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel Drug-Eluting Balloon Retrospective Market Scenario by Region
3.1 Global Paclitaxel Drug-Eluting Balloon Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Paclitaxel Drug-Eluting Balloon Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2018-2029
3.2.1 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2018-2023
3.2.2 Global Paclitaxel Drug-Eluting Balloon Sales by Region: 2024-2029
3.3 Global Paclitaxel Drug-Eluting Balloon Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2018-2029
3.3.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2018-2023
3.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Region: 2024-2029
3.4 North America Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.4.1 North America Paclitaxel Drug-Eluting Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2029)
3.4.3 North America Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.5.1 Europe Paclitaxel Drug-Eluting Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2029)
3.5.3 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel Drug-Eluting Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2029)
3.6.3 Asia Pacific Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel Drug-Eluting Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2029)
3.7.3 Latin America Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Paclitaxel Drug-Eluting Balloon Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel Drug-Eluting Balloon Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2029)
3.8.3 Middle East and Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2029)
4.1.1 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Sales by Type (2024-2029)
4.1.3 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2029)
4.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2018-2029)
4.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2018-2023)
4.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2024-2029)
4.2.3 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2018-2029)
4.3 Global Paclitaxel Drug-Eluting Balloon Price by Type (2018-2029)
5 Segment by Application
5.1 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2029)
5.1.1 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023)
5.1.2 Global Paclitaxel Drug-Eluting Balloon Sales by Application (2024-2029)
5.1.3 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2029)
5.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2018-2029)
5.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2018-2023)
5.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2024-2029)
5.2.3 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2018-2029)
5.3 Global Paclitaxel Drug-Eluting Balloon Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.3.4 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Cook Medical
6.4.1 Cook Medical Corporation Information
6.4.2 Cook Medical Description and Business Overview
6.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolio
6.4.5 Cook Medical Recent Developments/Updates
6.5 Cardionovum
6.5.1 Cardionovum Corporation Information
6.5.2 Cardionovum Description and Business Overview
6.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolio
6.5.5 Cardionovum Recent Developments/Updates
6.6 Aachen Resonance
6.6.1 Aachen Resonance Corporation Information
6.6.2 Aachen Resonance Description and Business Overview
6.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolio
6.6.5 Aachen Resonance Recent Developments/Updates
6.7 QT Vascular
6.6.1 QT Vascular Corporation Information
6.6.2 QT Vascular Description and Business Overview
6.6.3 QT Vascular Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.4.4 QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolio
6.7.5 QT Vascular Recent Developments/Updates
6.8 Biotronic
6.8.1 Biotronic Corporation Information
6.8.2 Biotronic Description and Business Overview
6.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolio
6.8.5 Biotronic Recent Developments/Updates
6.9 Philips
6.9.1 Philips Corporation Information
6.9.2 Philips Description and Business Overview
6.9.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Philips Paclitaxel Drug-Eluting Balloon Product Portfolio
6.9.5 Philips Recent Developments/Updates
6.10 Eurocor
6.10.1 Eurocor Corporation Information
6.10.2 Eurocor Description and Business Overview
6.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolio
6.10.5 Eurocor Recent Developments/Updates
6.11 Yinyi Biotech
6.11.1 Yinyi Biotech Corporation Information
6.11.2 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Description and Business Overview
6.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolio
6.11.5 Yinyi Biotech Recent Developments/Updates
6.12 Lepu Medical Technology
6.12.1 Lepu Medical Technology Corporation Information
6.12.2 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Description and Business Overview
6.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolio
6.12.5 Lepu Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel Drug-Eluting Balloon Industry Chain Analysis
7.2 Paclitaxel Drug-Eluting Balloon Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel Drug-Eluting Balloon Production Mode & Process
7.4 Paclitaxel Drug-Eluting Balloon Sales and Marketing
7.4.1 Paclitaxel Drug-Eluting Balloon Sales Channels
7.4.2 Paclitaxel Drug-Eluting Balloon Distributors
7.5 Paclitaxel Drug-Eluting Balloon Customers
8 Paclitaxel Drug-Eluting Balloon Market Dynamics
8.1 Paclitaxel Drug-Eluting Balloon Industry Trends
8.2 Paclitaxel Drug-Eluting Balloon Market Drivers
8.3 Paclitaxel Drug-Eluting Balloon Market Challenges
8.4 Paclitaxel Drug-Eluting Balloon Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
